Display options
Share it on

Transl Stroke Res. 2011 Jun;2(2):186-94. doi: 10.1007/s12975-010-0062-0. Epub 2011 Jan 11.

Dipyridamole Treatment Prior to Stroke Onset: Examining Post-stroke Cerebral Circulation and Outcome in Rabbits.

Translational stroke research

Christopher D d'Esterre, Kenneth M Tichauer, Richard I Aviv, Wolfgang Eisert, Ting-Yim Lee

Affiliations

  1. The University of Western Ontario, London, ON, Canada, [email protected].

PMID: 24323622 DOI: 10.1007/s12975-010-0062-0

Abstract

Clinical observations have indicated that secondary treatment with dipyridamole (DIP) may ameliorate stroke severity. The purpose of this study was to explore the effect of pre-stroke DIP treatment on stroke outcome in a rabbit model of embolic occlusion. Twenty male New Zealand white rabbits were randomly selected for intravenous treatment with DIP (n = 10) or saline (n = 10) for 7 days prior to an embolic cerebral occlusion by an autologous blood clot. Multiple computed tomography perfusion scans were acquired out to 28 days post-stroke to map cerebrohemodynamics, in conjunction with neurological assessments and histopathology. The DIP-treated group fared better than the saline group on several accounts: 66% of them survived to 28 days, whilst saline animals all had to be euthanized by day 7 due to severe neurological deficits. They presented with significantly more viable tissue in the ischemic hemisphere as well as fewer neurological deficits on days 4 and 7. Furthermore, DIP-treated animals exhibited improved cerebrohemodynamics by 24 h and had less incidence of haemorrhage within their infarcted regions (p < 0.05). DIP treatment prior to stroke onset can significantly improve neurological outcome, cerebral hemodynamics, and final infarct volume.

References

  1. Methods Find Exp Clin Pharmacol. 2005 Mar;27(2):95-100 - PubMed
  2. Lancet. 2007 Jan 27;369(9558):283-92 - PubMed
  3. Circulation. 2005 Feb 8;111(5):633-42 - PubMed
  4. J Neurol Sci. 2008 Jan 15;264(1-2):140-4 - PubMed
  5. Atherosclerosis. 1994 Nov;111(1):91-7 - PubMed
  6. Curr Opin Hematol. 2007 Jan;14(1):55-61 - PubMed
  7. Stroke. 2008 Apr;39(4):1358-63 - PubMed
  8. Prostaglandins. 1977 Sep;14(3):607-9 - PubMed
  9. BMJ. 2002 Oct 5;325(7367):762-5 - PubMed
  10. Stroke. 2010 Jun;41(6):1200-4 - PubMed
  11. Stroke. 2004 Nov;35(11 Suppl 1):2726-30 - PubMed
  12. Am J Physiol. 1995 Aug;269(2 Pt 1):C519-23 - PubMed
  13. Thromb Res. 2005;115(5):435-8 - PubMed
  14. AJNR Am J Neuroradiol. 1999 Jan;20(1):63-73 - PubMed
  15. J Cereb Blood Flow Metab. 1998 Dec;18(12):1365-77 - PubMed
  16. Radiology. 2008 Jun;247(3):818-25 - PubMed
  17. J Neurol Sci. 1996 Nov;143(1-2):1-13 - PubMed
  18. Novartis Found Symp. 2007;280:53-66; discussion 67-72, 160-4 - PubMed
  19. J Neurol. 2006 May;253(5):648-52 - PubMed
  20. Cerebrovasc Brain Metab Rev. 1994 Winter;6(4):341-60 - PubMed
  21. Surg Neurol. 2006 Sep;66(3):232-45 - PubMed
  22. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s39-42 - PubMed
  23. Mol Cell Biochem. 2007 Sep;303(1-2):19-25 - PubMed
  24. Eur J Clin Pharmacol. 1982;23(3):229-34 - PubMed
  25. Geriatrics. 1993 Jan;48(1):46, 51-3, 57-8 - PubMed
  26. Clin Phys Physiol Meas. 1988 Feb;9(1):65-74 - PubMed
  27. Vascul Pharmacol. 2008 Apr-Jun;48(4-6):143-9 - PubMed
  28. J Cereb Blood Flow Metab. 2008 Jul;28(7):1285-93 - PubMed
  29. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4888-93 - PubMed
  30. Am J Respir Cell Mol Biol. 1993 Aug;9(2):179-85 - PubMed
  31. AJNR Am J Neuroradiol. 2007 Apr;28(4):743-9 - PubMed
  32. Anesthesiology. 1998 Oct;89(4):954-60 - PubMed
  33. FASEB J. 2007 Nov;21(13):3666-76 - PubMed
  34. Neurology. 1999 Sep 11;53(4):825-9 - PubMed
  35. Neurotoxicology. 1991 Spring;12(1):9-21 - PubMed
  36. AJNR Am J Neuroradiol. 2003 Mar;24(3):419-26 - PubMed

Publication Types